Keratins are a group of cytoskeletal proteins that are found in human epide
rmis and other stratified squamous epithelia. Several different types of ke
ratins have been described. Keratin 10 (K10) is a keratin that is expressed
in well differentiated, suprabasal keratinocytes, and keratin 6 (K6) is a
keratin which is associated with hyperproliferation. Psoriasis is a chronic
inflammatory skin disease, and besides inflammation, disturbed differentia
tion and hyperproliferation are its hallmarks. In order to study the hyperp
roliferation associated keratinization in both well differentiated and poor
ly differentiated keratinocytes, and in order to assess the proliferative a
ctivity of all K10 and K6 subpopulations, simultaneous assessment of K6, K1
0,:and DNA content is required. So far, a triple staining protocol had not
been available. In the present study, we established a novel protocol for s
imultaneous measurement of K6, K10, and DNA content, which enables the char
acterization of the proliferative activity of several cellular subpopulatio
ns in epidermis. From 16 patients with psoriasis and from 15 healthy volunt
eers,:punch biopsies were obtained. After preparation of single cell suspen
sions, cells were stained with the anti-keratin 10 IgG(1)-isotype monoclona
l antibody RKSE60, with the anti-keratin 6 IgG(2a)-isotype monoclonal antib
ody LHK6B, and with the DNA fluorochrome TO-PRO-3 iodide. Isotype specific
secondary antibodies conjugated with phycoerythrein (PE) and fluorescein is
othiocyanate (FITC) were used as the second step in the staining procedure.
Controls were measured omitting the primary antibodies, and gates were set
:in order to differentiate between the K10 and K6 subpopulations. Samples f
rom both psoriatic patients and healthy volunteers were than measured. Owin
g to the IgG specificity of RKSE60 and LHK6B, no cross-reactivity was obser
ved between these antibodies. The triple staining with RKSE60, LHK6B, and T
O-PRO-3 iodide showed subpopulations of K10 expressing cells, K10/K6 cc-exp
ressing cells, and K6 only expressing cells. There was a significant differ
ence in the proportion of K6 expression and K10/K6 cc-expression between ps
oriatic and normal skin. Moreover, the proliferative activity of these subp
opulations could he quantified by this protocol. We concluded that a triple
staining protocol for the assessment of K6, K10, and DNA content, using th
e monoclonal antibodies LHK6B, RKSE60, and TO-PRO-3 iodide, supplies reliab
le and reproducible data for cellular studies on these keratins and for stu
dying the proliferative activity of the subpopulations of these keratins in
epidermis. Moreover, the present study showed that with respect to the pro
portion of K6, significant differences are present between psoriatic and he
althy human skin. (C) 2000 Wiley-Liss, Inc.